Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial
Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew navigation/help sections and metadata labels were added, including Last verified, Last known status was:, How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment, and a Revision: v3.6.0 line. The previous labels and formatting (e.g., Intervention / Treatment and Revision: v3.5.5) were replaced or removed.SummaryDifference1%

- Check15 days agoChange DetectedResults Submitted is now shown on the study record, and the page revision is updated to v3.5.5. This reflects that results have been submitted and the record has a newer version.SummaryDifference0.1%

- Check37 days agoChange DetectedVersion tag updated from v3.5.3 to v3.5.4, indicating a new release of the page. It represents an update to the page's metadata rather than a substantive change to the study information.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.5.3 is now displayed, replacing Revision: v3.5.2 on the page. This indicates a software update to the underlying component, with no changes to study content.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a new revision tag 'Revision: v3.5.2' and removed the older tag 'Revision: v3.5.0'.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded a new publication to the Publications section: Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis. Lancet Oncol. 2024 Nov;25(11):1465-1475.SummaryDifference0.1%

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.